Dermatology Billing Specialists
Mohs surgery. Biologic injections. Patch testing. Cosmetic appeals. Dermatology billing is among the most code-intensive in medicine — Healix RCM captures revenue other billing teams routinely miss.
Why Dermatology Billing Loses More Revenue Than Almost Any Other Specialty
Dermatology practices face a paradox: they perform high volumes of highly-reimbursed procedures, but the complexity of cosmetic vs. medical distinction, size-based excision coding, and multi-component Mohs billing means the gap between what practices earn and what they actually collect is enormous.
The average dermatology practice with an untrained billing team is collecting only 58–72% of its legitimate revenue. Healix RCM specializes exclusively in the code sets, modifiers, and appeal strategies that move that number above 95%.
- We code every Mohs case from the operative note — capturing all stages and reconstruction.
- We fight cosmetic denials with payer-specific LCD documentation — 94% win rate.
- We bill patch testing per allergen, not per session — 10x the revenue per visit.
- We track phototherapy frequency limits per payer to prevent cutoff denials.
- We manage biologic J-codes with correct NDC and unit calculations.
Why Dermatology Billing Is Uniquely Complex
1Cosmetic vs. Medically Necessary Distinction
The single most costly distinction in dermatology billing. Insurance carriers deny procedures coded as cosmetic even when medical necessity documentation exists. Treatments such as laser resurfacing for acne scars vs. active acne vulgaris, or excision of lipoma vs. sebaceous cyst, require impeccable diagnosis linkage to the procedure code. One wrong ICD-10 code triggers an automatic rejection — and incorrect appeals waste months of follow-up time.
2Mohs Surgery Multi-Stage Complexity
Mohs micrographic surgery (CPT 17311–17315) is among the most complex procedures to bill in any specialty. Each stage requires separate documentation including: tissue layer count, histologic margin status, lesion location and dimensions, and reconstruction method. Stage codes cannot be estimated in advance; intraoperative documentation drives the final code stack. Errors in stage count or missing reconstruction codes leave 15–30% of Mohs revenue unclaimed.
3Pathology Professional vs. Technical Component Split
When a dermatologist processes and interprets pathology in-house, they bill the global code. When they send specimens to an external lab, only the professional component (modifier -26) is billable by the practice. Failing to split these correctly — or double-billing by submitting global codes when only professional interpretation was performed — creates compliance exposure and payer audits.
4Biologic & Drug Administration Billing
Dupixent, Humira, Skyrizi, and Cosentyx injections carry J-codes (J0173, J0135, etc.) that must be billed with the exact NDC number, units administered, and route of administration. Step therapy documentation and prior authorization approvals must accompany every biologic claim. Missing NDC or incorrect units causes immediate denial from every major payer.
5Excision Size and Location-Based Coding
Excision codes (11400–11646) are determined by the combination of lesion type (benign vs. malignant), body location (trunk/extremities vs. face/ears/eyelids/lips), and the widest excised diameter including margins. A 1.9cm vs. 2.1cm excision on the face are completely different codes with 20–40% different reimbursement rates. Inaccurate measurement documentation or defaulting to 'common' codes causes systematic underpayment.
6Destruction Code Selection for Multiple Lesions
CPT 17000 covers the first lesion destroyed; 17001 covers each additional lesion (2nd through 14th); 17002 covers 15 or more lesions. When destruction and excision are performed in the same session on different lesions, both code sets can be billed with proper modifier -59 to unbundle. Practices that fail to add 17001 codes lose $40–$80 per additional lesion treated — across potentially hundreds of visits per month.
High-Volume Dermatology Codes We Bill — and Their Common Pitfalls
The most frequently missed or miscoded dermatology procedures, and exactly how Healix prevents each error.
| CPT Code | Description | Common Billing Pitfall |
|---|---|---|
| 17311 | Mohs surgery, trunk/extremities, first stage | Missing stage documentation, underreporting tissue blocks |
| 17312 | Mohs surgery, trunk/extremities, each additional stage | Not billing all stages; often 2–4 stages needed per case |
| 11642 | Excision, malignant lesion, face/lips/ears, 1.1–2.0cm | Wrong size range selected; body site coding error |
| 17000 | Destruction benign/premalignant lesion, first lesion | Failing to add 17001 for additional lesions |
| 11305 | Shave removal, trunk/extremities/head, 0.6–1.0cm | Confused with excision codes — different reimbursement rates |
| 96910 | Photochemotherapy with tar and UVB | Frequency edits; authorization required after initial sessions |
| 95044 | Patch or application test, each additional specimen | Not billing per allergen tested — major revenue loss |
| J0173 | Injection, dupilumab (Dupixent), 1mg | Missing NDC, unit calculation errors, step therapy missing |
Why Dermatology Claims Are Denied — and How Healix Resolves Each
These five denial types account for over 90% of all claim denials in dermatology practices. Each has a documented resolution pathway.
Cosmetic Exclusion Applied to Medical Procedure
Payers apply cosmetic exclusion clauses to procedures when the primary diagnosis code does not clearly establish medical necessity. Healix resolves this through appeal letters that cite the patient's documented pathology, relevant LCD policies, and CPT code intent — recovering over 94% of improperly cosmetic-coded denials.
Documentation Missing Lesion Size or Location
Excision and destruction codes are size- and site-dependent. When operative notes don't explicitly state the widest excised diameter including margins, and the anatomical location at the body-site specificity required by CPT, payers deny as 'coding not supported by documentation.' Our pre-submission audit catches these before claims are sent.
Pathology Report Doesn't Support Code Billed
When pathology results differ from the procedure code (e.g., benign result billed as malignant excision), payers retroactively deny and demand recoupment. Healix implements a post-pathology coding review workflow, ensuring final codes align with histologic outcomes — not the anticipated diagnosis at time of surgery.
Biologic Prior Authorization Missing or Expired
Biologic injections are denied when prior authorization was not obtained, has expired, or the administered drug didn't match the authorized drug. Healix manages biologic authorization calendars, renewal reminders 30 days in advance, and real-time eligibility verification at each injection visit.
Multiple Destruction Codes Incorrectly Bundled
Payers often bundle 17001 add-on codes for additional lesion destruction, claiming they are 'included in the primary code.' This is incorrect — 17001 is a valid separately payable add-on per AMA CPT guidelines. Healix includes modifier -59 documentation and appeals with CPT codebook authority when payers improperly bundle.
Three Revenue Opportunities Most Dermatology Practices Dramatically Underbill
These revenue streams are available in virtually every dermatology practice. They require no new equipment or additional patients — just the correct billing workflows.
Biologics Administration Suite
J0173, J0135, J2323 + Admin Code 96372
Dupixent (J0173), Humira (J0135), and Skyrizi (J2323) injections billed with the correct J-code, per-unit calculations, and the 96372 administration code represent major revenue. A practice administering 20 biologic injections per month can add $16,000–$64,000 in annual drug administration revenue — but only when the full code stack (J-code + admin + NDC) is correctly submitted.
Patch Testing Revenue
CPT 95044 × per allergen tested
Patch testing for allergic contact dermatitis is billed per allergen tested (CPT 95044), not per session. A standard 80-allergen panel correctly billed yields $4,800–$6,800 per session. Most practices submit a single global code instead of per-allergen billing, losing 60–70% of legitimate patch testing revenue.
Phototherapy Revenue Stream
CPT 96910 / 96912 / 96920
In-office phototherapy for psoriasis, vitiligo, and eczema (UVB, PUVA, narrow-band UVB) is highly reimbursed and requires very little physician time. A dedicated phototherapy lane generating 10 sessions per day adds $312,500 to $700,000 annually. The key is correct phototherapy code selection and frequency tracking to prevent payer-specific limit denials.
Our Dermatology Billing Process
A structured, specialty-specific workflow ensures nothing falls through the cracks — from pre-visit authorization to post-pathology code reconciliation.
Pre-Visit Chart Review & Authorization
We review upcoming procedures 5 business days in advance, verifying prior authorization status for biologics, phototherapy, and surgical procedures. Authorization numbers are pre-populated in your PM system before the patient arrives, eliminating day-of denial risk.
Operative Note Audit & Code Assignment
Immediately post-procedure, our dermatology billing specialists review operative notes for completeness — lesion dimensions, anatomical location, tissue layers (Mohs), and reconstruction method. We assign all code stacks including primary procedure + add-ons + J-codes before submitting.
Pathology Reconciliation
We maintain a pending pathology tracker for all excisions and shave removals. When pathology results return, we confirm that billed codes align with the histologic findings. If a discrepancy exists (e.g., benign result on malignant excision code), we correct the claim before it processes — preventing recoupment audits.
Clean Claim Submission & Scrubbing
Every claim is scrubbed against dermatology-specific NCCI edits, payer LCD policies, and our proprietary cosmetic-vs-medical ICD-10 mapping library before submission. Our 98.2% first-pass rate means consistent cash flow without AR aging.
Denial Management & Cosmetic Appeals
Cosmetic denials are worked within 48 hours using appeal templates that cite the relevant payer LCD, ICD-10 medical necessity linkage, and operative documentation. Our 94% cosmetic appeal success rate recovers revenue most practices write off as uncollectible.
Dermatology Billing Results We Deliver
Measurable outcomes from practices that switched to Healix RCM within the first 90 days.
Dermatology-specialized EHR systems we work with natively
Dermatology Billing FAQs
Real answers to the billing questions dermatology practices ask us most.
QHow do we appeal a cosmetic exclusion denial for a medically necessary procedure?
The appeal must contain three elements: (1) A letter of medical necessity from the treating dermatologist explicitly stating the diagnosis and why the procedure is curative/medically required, not cosmetic; (2) The exact payer LCD or coverage policy language that supports coverage for the diagnosed condition; (3) Supporting clinical documentation — biopsy report, pathology results, or prior treatment failure records. Healix maintains specialty-specific appeal templates for every major payer's dermatology LCD that our billers can deploy within 24 hours of a cosmetic denial.
QHow is Mohs surgery billed — and why are multiple stages important to document?
Mohs surgery is billed per stage, not per procedure. CPT 17311 covers the first stage on trunk/extremities (head/neck uses 17313). Each additional stage adds CPT 17312 (trunk) or 17314 (head/neck). A 3-stage Mohs on the nose at current Medicare rates generates approximately $1,400–$1,800 per stage set — but only if intraoperative documentation explicitly logs each stage's tissue processing and margin status. Healix reviews Mohs operative notes immediately after the case to ensure all stages are captured before patients leave the facility.
QCan we bill for both the excision and the pathology interpretation?
Yes — when a dermatologist performs the excision AND provides the pathologic interpretation in-house (owns the lab). You bill the surgical CPT code and the 88305 pathology code with modifier -26 (professional component) if you read the slide but a reference lab processed the tissue, or the global 88305 if your lab both processes and interprets. If you send specimens to an external pathology lab, the lab bills 88305-TC (technical component), and you bill 88305-26 only for your interpretation. Healix maps your lab arrangement to the correct billing pattern at onboarding.
QWhat is the correct way to bill patch testing (95044)?
CPT 95044 is an add-on code billed per additional allergen tested after the first. The correct billing for an 80-allergen patch test panel is: one unit of the appropriate evaluation code plus 79 units of 95044 (one per additional allergen). Many practices submit patch testing as a single service, capturing only $50–$80 instead of the $4,000–$6,000+ that correct per-allergen billing generates. Payers that limit patch testing units will deny excess units — Healix tracks each payer's patch test limit and chooses the optimal panel size for that payer.
QHow do biologic J-codes work, and what is needed to bill them correctly?
J-codes for biologics (e.g., J0173 for dupilumab/Dupixent) must be billed with three data elements: (1) The exact NDC (National Drug Code) of the vial administered; (2) The number of units based on the drug's billing unit (J0173 = per 1mg, so a 200mg dose bills 200 units of J0173); (3) An active prior authorization number matching the specific drug. Missing any one of these elements causes an immediate denial. Healix maintains a biologic drug billing matrix with units-per-dose calculations for all major dermatology biologics, reducing biologic denial rates to under 3%.
QWhat modifiers does dermatology use most, and when do we use them?
The most important dermatology modifiers are: -59 (distinct procedural service — used when billing destruction codes alongside excision in the same session on different lesions); -26 (professional component only — for pathology interpretation); -TC (technical component only — for lab processing without interpretation); -51 (multiple procedures — for bilateral lesions when not using bilateral-specific codes); -58 (staged or related procedure by same surgeon — for planned Mohs reconstruction staged separately from the Mohs itself). Modifier misuse is a top audit trigger — Healix audits modifier patterns monthly against NCCI edit tables.
QHow often will Medicare pay for phototherapy, and what triggers a frequency denial?
Medicare covers NB-UVB (narrow-band UVB) and PUVA phototherapy for documented chronic plaque psoriasis or vitiligo. There is no hard session limit, but payers expect a treatment response evaluation at 6–8 week intervals. Frequency denials occur when sessions exceed 3 per week without a documented treatment plan, when the diagnoses are not entered correctly (L40.0 for psoriasis vulgaris, L80 for vitiligo), or when the prior authorization lapses. Healix tracks each patient's phototherapy authorization and session count, alerting staff when frequency limits approach.
QCan we separately bill laser therapy and an office visit on the same day?
Yes — with modifier -25 on the E/M code. If the physician sees the patient, makes a separate medical decision (e.g., disease progression assessment), and then performs laser therapy, both the E/M and the laser procedure code are billable. Without modifier -25, payers bundle the E/M as included in the procedure code. The key requirement is that the E/M must reflect a 'significant, separately identifiable service' with its own documentation beyond the pre-procedure assessment. Healix audits same-day E/M + procedure claims to ensure modifier -25 is correctly applied and supported.
Ready to Optimize Your Dermatology Billing?
Get a free audit of your Mohs surgery billing, cosmetic denial rate, and patch testing revenue. We'll show you exactly how much your practice is leaving behind — with no obligation to sign.